Navigation Links
Januvia Lawsuits Move Forward, With Scheduling of Next Status Conference in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports
Date:11/9/2013

New York, New York (PRWEB) November 09, 2013

The federal multidistrict litigation established for Januvia lawsuits (http://www.januvialawsuithelp.com) will hold its next Status Conference on November 21, 2013, Bernstein Liebhard LLP reports. According to court filings, at least 150 lawsuits involving Januvia and other Type 2 diabetes drugs in the incretin mimetics class are now pending in the federal proceeding, which is underway in U.S. District Court, Southern District of California. All of the claims filed in the litigation allege that doctors and patients were not provided with adequate warnings regarding a potential association between medications like Januvia and pancreatic cancer. (In Re: Incretins Products Liability, Sales and Marketing Litigation, MDL 2452)

“Our Firm is pleased with the progress of this litigation thus far, as we continue to hear from Januvia patients who are concerned that this drug may have caused them to develop pancreatic cancer, as well as pancreatitis and thyroid cancer,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is offering free Januvia lawsuit evaluations to individuals who were allegedly harmed by this medication.

Januvia and Pancreatic Cancer
Januvia and other incretin mimetic drugs work by copying the action of incretin hormones in the digestive tract to stimulate the production of insulin by the pancreas. In 2009, a caution regarding a link between Januvia and pancreatitis – a risk factor for pancreatic cancer - was added to the drug’s label after the U.S. Food & Drug Administration (FDA) became aware of 88 instances where Januvia patients had developed acute pancreatitis.* Since then, additional studies have raised concerns that drugs like Januvia may have harmful affects on the pancreas, includ
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. DrugRisk Updates with Latest Case Numbers Since Januvia Lawsuits Sent to MDL Court
2. DrugRisk Update: Januvia Lawsuits Alleging Cancer Headed to Federal Court
3. DrugRisk News: Court Consolidates Januvia Lawsuits Alleging Cancer
4. Januvia Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Order Transferring Federal Claims Over Januvia and Pancreatic Cancer to California Federal Court
5. Januvia Lawsuits Being Investigated By Bernstein Liebhard LLP on Behalf of Januvia Patients Who Were Diagnosed with Pancreatic Cancer, Pancreatitis and Thyroid Cancer
6. Januvia Pancreatic Cancer Lawsuit: Bernstein Liebhard LLP Comments on Growing Litigation Surrounding Januvia
7. Federal Byetta, Victoza, Januvia Lawsuits Could See Consolidation This Month, Rottenstein Law Group LLP Reports
8. Rottenstein Law Group LLP Acknowledges BMJ Study of Risks of Byetta, Januvia
9. New analysis shows that patients with Type 2 diabetes and mild renal impairment had similar improvement in blood sugar control and experienced less hypoglycemia with JANUVIA (sitagliptin) compared to sulfonylurea
10. DrugRisk Update: Panel To Decide Fate of Januvia Lawsuits Next Week
11. Januvia Pancreatic Cancer Lawsuits: Bernstein Liebhard LLP Comments on Medical Journal’s Investigation of Incretin Mimetics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 2014) The Columbia University College of Dental ... Excellence in Diversity (HEED) award from INSIGHT Into ... in higher education. As a recipient of the ... and universities that demonstrate an outstanding commitment to ... 82 other recipients in INSIGHT Into Diversity magazine,s ...
(Date:9/16/2014)... 2014. Kessler Foundation researchers have published a study ... the executive deficits found in individuals with multiple ... for executive deficits in multiple sclerosis? Evidence from ... ahead of print on August 18 by ... Victoria Leavitt, PhD, of the Manhattan Memory Center, ...
(Date:9/16/2014)... some of Australia,s best fast bowlers, track and field ... thanks to a new training technique discovered by a ... of Health and Biomedical Innovation, with support from the ... Sport Science Research, has studied the run-ups of elite ... jump and pole vault and found the vertical objects ...
(Date:9/16/2014)... September 15, 2014 For patients with locally advanced ... ablative radiation (SABR) may be a promising treatment ... may not otherwise be an option, according to ... Radiation Oncology,s (ASTRO,s) 56th Annual Meeting. , Surgery ... with pancreatic ductal adenocarcinoma (PDA), the most common ...
(Date:9/16/2014)... abstracts to be presented at the ESMO 2014 Congress ... at 12:00 (CEST) to give you a first glimpse ... oncology Congress, under the leading theme Precision Medicine in ... genuinely targeted therapy is now possible for an increasing ... all working towards a common goal --improved patient outcomes. ...
Breaking Medicine News(10 mins):Health News:Columbia University College of Dental Medicine receives diversity award 2Health News:Columbia University College of Dental Medicine receives diversity award 3Health News:Columbia University College of Dental Medicine receives diversity award 4Health News:Getting the jump on competitors: QUT study 2Health News:Chemotherapy and SABR consecutively may be promising treatment option for advanced pancreatic cancer 2Health News:Chemotherapy and SABR consecutively may be promising treatment option for advanced pancreatic cancer 3Health News:Chemotherapy and SABR consecutively may be promising treatment option for advanced pancreatic cancer 4Health News:ESMO 2014 Congress Preview 2
... According to a research it was found that radiotherapy given ... against breast cancer//. The researchers from UK and US said ... the recurrence of cancer when compared to the conventional regime ... of the 10-year trial which was funded by the Cancer ...
... with stimulant medications rather than nonstimulant medications or ... such as mixed amphetamine salts (MAS) and methylphenidates ... medications such as modafinil. ,This conclusion is ... representing the past 25 years of research involving ...
... mobilisation against the disease in the last five years, frustrating ... UN says in advance of a review conference. ,A ... are scheduled to meet Wednesday-Friday at UN headquarters to assess ... General Assembly to try to reverse the epidemic by 2010. ...
... of genetically caused diseases from type 1 diabetes to alopecia, ... system, autoimmune disease can be understood//. ,By age ... infection of the skin and/or mucous membrane and adrenal gland ... in the Aire gene) and nearly about 16 autoimmune diseases ...
... were suffered, was caused by distinctly personal habits and ... do but to suffer in silence. Others like constipation, ... limiting some of their day-to-day activities. ,Researches ... modification instead of taking variety of drugs. ...
... statistics regarding the use of tobacco amongst teenagers, which has ... tobacco and its products. , ,These figures were made ... World No Tobacco Day; on May 31st. This years theme ... or disguise,'' conveying cigarette smoking in any form is extremely ...
Cached Medicine News:Health News:Stimulant Medications More Effective In Treating ADHD Than Nonstimulants 2Health News:Global War Against AIDS May Fail Target, Warns UN 2Health News:Autoimmune Diseases – Newer Preventive Measure 2Health News:Autoimmune Diseases – Newer Preventive Measure 3Health News:Silence Puts Comfort For Digestive Syndrome 2
(Date:9/16/2014)... 2014  DNAtrix, Inc., experts in oncolytic virus ... treated with the company,s lead product, DNX-2401, a ... randomized, multicenter, open-label Phase Ib study for patients ... with leading neurosurgeons and neuro-oncologists in the US, ... randomized Phase Ib study of DNX-2401 at Moffitt ...
(Date:9/16/2014)... 16, 2014 Henry Schein, Inc. (NASDAQ: ... of health care products and services to office-based ... that Stanley M. Bergman, Henry Schein,s Chairman of the Board ... healthcare services panel at the Leerink Partners Services ... be Dr. Stohler, Dean of Columbia University,s College ...
(Date:9/16/2014)... BOSTON , September 16, 2014 ... Fiona Marshall , will give a presentation entitled " ... StaR ®   technology " ... and Development " virtual symposium run by Chemical & Engineering ... symposium is on Wednesday, 24 September 2014; Dr Marshall,s presentation ...
Breaking Medicine Technology:DNAtrix Announces Treatment Of First Patient With DNX-2401 In Recurrent Glioblastoma Trial 2Henry Schein To Present At The Leerink Partners Services Roundtable 2Heptares to Present on Structure-Based Drug Design Using G Protein-Coupled Receptors at Inaugural Chemistry & Engineering News Virtual Symposium 2
... N.J., May 24, 2012 Watson Pharmaceuticals, Inc. ... its subsidiary, Watson Laboratories, Inc., filed an Abbreviated ... and Drug Administration (FDA) seeking approval to market ... is a generic version of Auxilium Pharmaceuticals, Inc.,s ...
... ANTONIO, May 24, 2012 /PRNewswire-iReach/ -- An ... Life Science Venture Forum in Houston, Texas named TransCU ... of ten Most Promising Life Science Technologies .  ... and innovations to hundreds of early-stage investors, venture capitalists, ...
Cached Medicine Technology:Watson Confirms Testim® Patent Challenge 2Watson Confirms Testim® Patent Challenge 3New Chronic Wound Therapy Awarded at Texas' Largest Life Science Event 2
... KIMBERLY-CLARK CLOtest Rapid Urease Test is ... Standard among urease tests because of its ... by Barry Marshall, MD. who, along with ... discover the correlation between H. pylori and ...
... Rapid Test Strip and Device are rapid ... antibodies to Helicobacter pylori (H. pylori) in ... in the diagnosis of H. pylori infection ... older. They are intended for health professionals ...
... pylori WB test is a ... detection of lgG antibodies specific ... whole blood. This test kit ... in the diagnosis of H.pylori ...
... based on a lateral flow chromatography ... the qualitative detection of Helicobacter pylori ... Platinum HpSA, a microtiter assay from ... accepted as an accurate tool for ...
Medicine Products: